{"id":17528,"date":"2025-09-19T21:10:09","date_gmt":"2025-09-19T18:10:09","guid":{"rendered":"https:\/\/testsunucusu.com\/acibadem\/doctor\/umut-disel\/"},"modified":"2025-12-10T18:48:00","modified_gmt":"2025-12-10T15:48:00","slug":"umut-disel","status":"publish","type":"idel_doctor","link":"https:\/\/acibademinternational.com\/doctor\/umut-disel\/","title":{"rendered":"Umut Di\u015fel"},"content":{"rendered":"

<\/p>\n

\n

Assoc. Prof. Umut Di\u015fel<\/strong> is a medical oncologist with a strong clinical and academic background. He earned his medical oncology qualification in 2017 and has since combined patient care, teaching, and research. In 2018 he joined Ac\u0131badem Health Group, where he provides comprehensive oncology care and participates in multidisciplinary treatment planning. He is an active member of the Medical Oncology Society and the Anatolian Medical Oncology Association, contributing to professional development and collaboration within the oncology community. Known for a patient-centered approach, he focuses on evidence-based treatments and clear communication to support patients and families through diagnosis and therapy.<\/p>\n

<\/div>\n

Education<\/strong><\/p>\n

    \n
  • 2017<\/span> Medical Oncology \/ Associate Professor<\/span><\/li>\n
  • 2005<\/span> Cukurova University Faculty of Medicine Medical Oncology<\/span><\/li>\n
  • 2001<\/span> \u00c7ukurova University Faculty of Medicine Internal Medicine<\/span><\/li>\n
  • 1995<\/span> Cukurova University Faculty of Medicine<\/span><\/li>\n<\/ul>\n

    Experience<\/strong><\/p>\n

      \n
    • 2018<\/span> Acibadem Health Group<\/span><\/li>\n<\/ul>\n

      Memberships<\/strong><\/p>\n

        \n
      • Medical Oncology Society<\/span><\/li>\n
      • Anatolian Medical Oncology Association<\/span><\/li>\n<\/ul>\n

        Publications<\/strong><\/p>\n

          \n
        • Which patients with advanced cancer and biliary obstruction benefit from biliary stenting most? An analysis of prognostic factors<\/strong>
          \nSupportive Care in Cancer, 21(4), 1131-1135., Number of Citation: 2, Doi: 10.1007\/s00520-012-1636-z ABALI H\u00dcSEY\u0130N,SEZER AHMET.O\u011fuzkurt Levent.GUREL KAM\u0130L,\u00d6zkan U\u011fur.Be\u015fen Ali Ayberk, S\u00dcMB\u00dcL AHMET TANER,K\u00d6SE FAT\u0130H,D\u0130\u015eEL UMUT<\/li>\n
        • Acute infusion reactions to chemotherapeutic drugs: A single institute experience.<\/strong>
          \nJOURNAL OF BALKAN UNION OF ONCOLOGY, 18(1), 261-267., Number of Citation: 1, (Control No: 1606723) MUALLAOGLU SADIK.D\u0130\u015eEL UMUT.MERTSOYLU H\u00dcSEY\u0130N,BESEN ALI AYBERK,KARADEN\u0130Z CEM\u0130LE, S\u00dcMB\u00dcL AHMET TANER.ABALI H\u00dcSEY\u0130N,\u00d6ZYILKAN \u00d6ZG\u00dcR<\/li>\n
        • Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience<\/strong>
          \nEuropean Journal of Radiology, 81(8), 1724-1727., Number of Citation: 3, Doi: 10.1016\/j.ejrad.2011.04.056 K\u00d6SE FAT\u0130H,OGUZKURT LEVENT.BESEN ALI AYBERK.S\u00dcMB\u00dcL AHMET TANER,SEZER AHMET, Karadeniz Cemile.D\u0130\u015eEL UMUT.MERTSOYLU H\u00dcSEY\u0130N,\u00d6ZYILKAN \u00d6ZG\u00dcR<\/li>\n
        • A case report of bevacizumab-related osteonecrosis of the jaw: Old problem, new culprit.<\/strong>
          \nOral Oncology, 48(2), 2-3., Number of Citation: 13, Doi: 10.1016\/j.oraloncology.2011.07.030, D\u0130\u015eEL UMUT.Be\u015fen Ali Ayberk.Be\u015fen Ali Ayberk.\u00d6ZYILKAN \u00d6ZG\u00dcR.Er Efsun,CANPOLAT EM\u0130NE TUBA<\/li>\n
        • Secondary malignancy after imatinib therapy: eight cases and review of the literature<\/strong>
          \nLeukemia & Lymphoma, 53(9), 1706\u00ac1708., Number of Citation: 7, Doi: 10.3109\/10428194.2012.666545 BOZKURT DUMAN BERNA.PAYDA\u015e SEMRA.D\u0130\u015eEL UMUT BESEN AYBERK,G\u00dcRKAN EMEL<\/li>\n
        • Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer:<\/strong>
          \nThe Ba\u015fkent University experience. Asian Pacific Journal of Cancer Prevention, 12(5), 1185-1188., Number of Citations: 1 K\u00d6SE FATI\u0307H,BESEN ALI AYBERK.S\u00dcMB\u00dcL AHMET TANER,SEZER AHMET.KARADENIZ CEMI\u0307LE, DI\u0307\u015eEL UMUT.ALTUNDAG \u00d6ZDEN,\u00d6ZYILKAN \u00d6ZG\u00dcR<\/li>\n
        • Hypertension Associated With Angiogoenesis Inhibitors: What Do Oncologists Really Do in Daily Routine? A Small Survey<\/strong>
          \nThe Journal of Clinical Hypertension, 13(11), 863-863., Citation: 0, Doi: 10.1111 \/j.1751-7176.2011.00526. D\u0130\u015eEL UMUT.ABALI H\u00dcSEY\u0130N.S\u00dcMB\u00dcL AHMET TANER.\u00d6ZYILKAN \u00d6ZG\u00dcR<\/li>\n
        • Letter to the editor. Supportive Care in Cancer<\/strong>
          \n18(6), 657-658., Citation: 0, Doi: 10.1007\/s00520-010- 0842-9, K\u00d6SE FAT\u0130H.Abali Huseyin.Ayberk Besen,D\u0130\u015eEL UM UT, HAYRAN KAD\u0130R MUTLU<\/li>\n
        • Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine<\/strong>
          \nCutaneous and Ocular Toxicology, 29(2), 140-142., Number of Citation: 5, Doi: 10.3109\/15569521003699585 D\u0130\u015eEL UMUT.GURKUT OZLEM.ABALI H\u00dcSEY\u0130N.KALEA\u011eASI \u015e\u00dcKR\u00dc HAKAN,MERTSOYLU H\u00dcSEY\u0130N, \u00d6ZYILKAN \u00d6ZG\u00dcR.Muhammad Wasif Saif<\/li>\n
        • Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab.<\/strong>
          \nChemotherapy, 56(2), 89- 93., Citation Count: 5, Doi: 10.1159\/000305255, D\u0130\u015eEL UMUT.PAYDA\u015e SEMRA,YAVUZ S\u0130NAN,KARAKO\u00c7 EMRE<\/li>\n<\/ul>\n<\/div>\n","protected":false},"featured_media":17529,"template":"","categories":[12,4,892,842],"class_list":["post-17528","idel_doctor","type-idel_doctor","status-publish","has-post-thumbnail","hentry","category-adana-hospital","category-doctors","category-internal-medicine","category-oncology"],"_links":{"self":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor\/17528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor"}],"about":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/types\/idel_doctor"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media\/17529"}],"wp:attachment":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media?parent=17528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/categories?post=17528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}